HKD 4.67
(1.52%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 3.85 Billion CNY | 11.19% |
2022 | 3.46 Billion CNY | 0.94% |
2021 | 3.43 Billion CNY | 7.72% |
2020 | 3.18 Billion CNY | 4.38% |
2019 | 3.05 Billion CNY | 22.56% |
2018 | 2.49 Billion CNY | 3.18% |
2017 | 2.41 Billion CNY | 5.09% |
2016 | 2.29 Billion CNY | 121.01% |
2015 | 1.04 Billion CNY | -5.09% |
2014 | 1.09 Billion CNY | -3.82% |
2013 | 1.13 Billion CNY | 20.63% |
2012 | 944.69 Million CNY | 7.5% |
2011 | 878.8 Million CNY | 100.34% |
2010 | 438.65 Million CNY | 46.74% |
2009 | 298.94 Million CNY | -3.65% |
2008 | 310.27 Million CNY | -5.33% |
2007 | 327.75 Million CNY | -26.99% |
2006 | 448.91 Million CNY | -1.28% |
2005 | 454.76 Million CNY | 3.49% |
2004 | 439.42 Million CNY | 91.44% |
2003 | 229.54 Million CNY | 0.26% |
2002 | 228.94 Million CNY | 53.43% |
2001 | 149.21 Million CNY | 21.81% |
2000 | 122.49 Million CNY | -13.55% |
1999 | 141.7 Million CNY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 4.44 Billion CNY | 0.0% |
2023 Q2 | 3.77 Billion CNY | 0.0% |
2023 Q4 | 3.85 Billion CNY | 0.0% |
2023 FY | 3.85 Billion CNY | 11.19% |
2022 FY | 3.46 Billion CNY | 0.94% |
2022 Q2 | 3.94 Billion CNY | 0.0% |
2022 Q4 | 3.46 Billion CNY | 0.0% |
2021 Q2 | 4.31 Billion CNY | 0.0% |
2021 FY | 3.43 Billion CNY | 7.72% |
2021 Q4 | 3.43 Billion CNY | 0.0% |
2020 Q2 | 3.69 Billion CNY | 0.0% |
2020 Q4 | 3.18 Billion CNY | 0.0% |
2020 FY | 3.18 Billion CNY | 4.38% |
2019 FY | 3.05 Billion CNY | 22.56% |
2019 Q2 | 2.66 Billion CNY | 0.0% |
2019 Q4 | 3.05 Billion CNY | 0.0% |
2018 FY | 2.49 Billion CNY | 3.18% |
2018 Q2 | 2.8 Billion CNY | 0.0% |
2018 Q4 | 2.49 Billion CNY | 0.0% |
2017 FY | 2.41 Billion CNY | 5.09% |
2017 Q4 | 2.41 Billion CNY | 0.0% |
2017 Q2 | 2.8 Billion CNY | 0.0% |
2016 FY | 2.29 Billion CNY | 121.01% |
2016 Q2 | 1.53 Billion CNY | 0.0% |
2016 Q4 | 2.29 Billion CNY | 0.0% |
2015 FY | 1.04 Billion CNY | -5.09% |
2015 Q4 | 1.04 Billion CNY | 0.0% |
2015 Q2 | 1.42 Billion CNY | 0.0% |
2014 FY | 1.09 Billion CNY | -3.82% |
2014 Q2 | 1.48 Billion CNY | 0.0% |
2014 Q4 | 1.09 Billion CNY | 0.0% |
2013 Q4 | 1.13 Billion CNY | 0.0% |
2013 FY | 1.13 Billion CNY | 20.63% |
2013 Q2 | 1.2 Billion CNY | 0.0% |
2012 Q2 | 1.08 Billion CNY | 0.0% |
2012 Q4 | 944.69 Million CNY | 0.0% |
2012 FY | 944.69 Million CNY | 7.5% |
2011 FY | 878.8 Million CNY | 100.34% |
2011 Q2 | 691.75 Million CNY | 0.0% |
2011 Q4 | 878.8 Million CNY | 0.0% |
2010 Q4 | 438.65 Million CNY | 0.0% |
2010 FY | 438.65 Million CNY | 46.74% |
2010 Q2 | 450.27 Million CNY | 0.0% |
2009 FY | 298.94 Million CNY | -3.65% |
2009 Q4 | 298.94 Million CNY | 0.0% |
2008 FY | 310.27 Million CNY | -5.33% |
2007 FY | 327.75 Million CNY | -26.99% |
2006 FY | 448.91 Million CNY | -1.28% |
2005 FY | 454.76 Million CNY | 3.49% |
2004 FY | 439.42 Million CNY | 91.44% |
2003 FY | 229.54 Million CNY | 0.26% |
2002 FY | 228.94 Million CNY | 53.43% |
2001 FY | 149.21 Million CNY | 21.81% |
2000 FY | 122.49 Million CNY | -13.55% |
1999 FY | 141.7 Million CNY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
CSPC Pharmaceutical Group Limited | 12.02 Billion HKD | 67.94% |